Literature DB >> 22951441

The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway.

Gavin Thurston1, Christopher Daly.   

Abstract

The angiopoietin-Tie signaling system is a vascular-specific receptor tyrosine kinase pathway that is essential for normal vascular development. Although the basic functioning of the pathway is understood, many uncertainties remain about the role of certain members of the pathway, particularly angiopoietin-2 (Ang2), in pathological vascular remodeling and angiogenesis. We summarize the components of the angiopoietin-Tie pathway and then focus on studies that highlight the role of Ang2 in disease settings, including cancer and inflammation. The expression of Ang2 is elevated in many cancers and types of inflammation, which prompted the development of specific reagents to block its interaction with the Tie2 receptor. The application of these reagents in preclinical models of inflammation and cancer has begun to elucidate the role of Ang2 in vascular remodeling and disease pathogenesis and has led to emerging clinical tests of Ang2 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951441      PMCID: PMC3426817          DOI: 10.1101/cshperspect.a006650

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  71 in total

1.  Angiopoietin-2-driven vascular remodeling in airway inflammation.

Authors:  Sebastien P Tabruyn; Katharine Colton; Tohru Morisada; Jonas Fuxe; Stanley J Wiegand; Gavin Thurston; Anthony J Coyle; Jane Connor; Donald M McDonald
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

2.  Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.

Authors:  Hai Tao Yuan; Shivalingappa Venkatesha; Barden Chan; Urban Deutsch; Tadanori Mammoto; Vikas P Sukhatme; Adrian S Woolf; S Ananth Karumanchi
Journal:  FASEB J       Date:  2007-05-15       Impact factor: 5.191

3.  Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.

Authors:  I Kim; H G Kim; J N So; J H Kim; H J Kwak; G Y Koh
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

4.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

Authors:  G Thurston; C Suri; K Smith; J McClain; T N Sato; G D Yancopoulos; D M McDonald
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.

Authors:  Hanhua Huang; Jing-Yu Lai; Janet Do; Dingguo Liu; Lingna Li; Joselyn Del Rosario; Venkata R Doppalapudi; Steven Pirie-Shepherd; Nancy Levin; Curt Bradshaw; Gary Woodnutt; Rodney Lappe; Abhijit Bhat
Journal:  Clin Cancer Res       Date:  2011-01-13       Impact factor: 12.531

6.  Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.

Authors:  Angela Coxon; James Bready; Hosung Min; Stephen Kaufman; Juan Leal; Dongyin Yu; Tani Ann Lee; Ji-Rong Sun; Juan Estrada; Brad Bolon; James McCabe; Ling Wang; Karen Rex; Sean Caenepeel; Paul Hughes; David Cordover; Haejin Kim; Seog Joon Han; Mark L Michaels; Eric Hsu; Grant Shimamoto; Russell Cattley; Eunju Hurh; Linh Nguyen; Shao Xiong Wang; Anthony Ndifor; Isaac J Hayward; Beverly L Falcón; Donald M McDonald; Luke Li; Tom Boone; Richard Kendall; Robert Radinsky; Jonathan D Oliner
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

7.  Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy.

Authors:  V Goede; O Coutelle; J Neuneier; A Reinacher-Schick; R Schnell; T C Koslowsky; M R Weihrauch; B Cremer; H Kashkar; M Odenthal; H G Augustin; W Schmiegel; M Hallek; U T Hacker
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

8.  Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity.

Authors:  Joshua S Davis; Tsin W Yeo; Kim A Piera; Tonia Woodberry; David S Celermajer; Dianne P Stephens; Nicholas M Anstey
Journal:  Crit Care       Date:  2010-05-18       Impact factor: 9.097

9.  Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts.

Authors:  Pipsa Saharinen; Lauri Eklund; Juho Miettinen; Riikka Wirkkala; Andrey Anisimov; Mark Winderlich; Astrid Nottebaum; Dietmar Vestweber; Urban Deutsch; Gou Young Koh; Bjorn R Olsen; Kari Alitalo
Journal:  Nat Cell Biol       Date:  2008-04-20       Impact factor: 28.824

10.  Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Arne Scholz; Vanessa Annina Rehm; Svenja Rieke; Katja Derkow; Petra Schulz; Konrad Neumann; Inga Koch; Maria Pascu; Bertram Wiedenmann; Thomas Berg; Eckart Schott
Journal:  Am J Gastroenterol       Date:  2007-06-20       Impact factor: 10.864

View more
  82 in total

Review 1.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

2.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

Review 3.  The role of inflammation in diabetic eye disease.

Authors:  Marina Mesquida; Faye Drawnel; Sascha Fauser
Journal:  Semin Immunopathol       Date:  2019-06-07       Impact factor: 9.623

4.  Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.

Authors:  Patrick Koenig; Chingwei V Lee; Sarah Sanowar; Ping Wu; Jeremy Stinson; Seth F Harris; Germaine Fuh
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

5.  Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.

Authors:  Xinqi Wu; Anita Giobbie-Hurder; Xiaoyun Liao; Courtney Connelly; Erin M Connolly; Jingjing Li; Michael P Manos; Donald Lawrence; David McDermott; Mariano Severgnini; Jun Zhou; Evisa Gjini; Ana Lako; Mikel Lipschitz; Christine J Pak; Sara Abdelrahman; Scott Rodig; F Stephen Hodi
Journal:  Cancer Immunol Res       Date:  2016-12-21       Impact factor: 11.151

Review 6.  Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progression.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

7.  miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.

Authors:  Ruijing Lu; Ziliang Ji; Xiaoqing Li; Qingna Zhai; Chunjuan Zhao; Zhimao Jiang; Shiqiang Zhang; Liping Nie; Zhendong Yu
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-03       Impact factor: 4.553

8.  Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.

Authors:  Melissa K Brunckhorst; Yin Xu; Rong Lu; Qin Yu
Journal:  Am J Pathol       Date:  2014-08       Impact factor: 4.307

Review 9.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

Review 10.  The chlorinated lipidome originating from myeloperoxidase-derived HOCl targeting plasmalogens: Metabolism, clearance, and biological properties.

Authors:  Elisa N D Palladino; Celine L Hartman; Carolyn J Albert; David A Ford
Journal:  Arch Biochem Biophys       Date:  2018-01-31       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.